Herein, we report a case of advanced lung adenocarcinoma associated with the MPRIP-ROS1 fusion gene, a rare ROS1 rearrangement, detected using a comprehensive genomic profiling test in a patient with remarkable tumor response to crizotinib. This evidence concerns the gene ROS1 and neoplasm.